Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
With the growth of telehealth in Australia, an increasing number of patients are consulting prescribers online and having medications dispensed through registered online pharmacies
Patients also find a significant decline in food obsession, allowing them to focus on other areas of life
Aftercare: You can return to daily activities with no downtime
Some patients report improved energy levels due to weight loss and better blood sugar control, while others may experience mild fatigue in the first few weeks of treatment
What the Research Shows Large clinical studies have consistently demonstrated: Significant weight loss in many patients Improved blood sugar control Improvements in metabolic markers Cardiovascular benefits in certain populations These findings have contributed to the growing use of GLP-1 medications in obesity and metabolic health management
Results Between October 2019 and October 2021, a total of 774 participants were screened and 521 participants were randomised to oral semaglutide 3 mg ( n =130), 7 mg ( n =130), 14 mg ( n =130) or placebo ( n =131)
US$ 22.05
US$ 24.79
US$ 27.96
US$ 28.96
